Older adults with atopic eczema are more prone to dementia. Chronic inflammation has emerged as a key predictor and mechanism in the initiation and progression of neuropathologic alterations reported in dementia patients. Atopic eczema, also…
MDNewsline DailyJanuary 30, 2023
Toleriane, a dermo-cosmetic, is effective for eyelid eczema. Eyelid eczema (EE) is clearly defined clinically and medically, yet it remains a complex pathology. In addition to its frequent resistance to medication and susceptibility to relapse,…
MDNewsline DailyJanuary 30, 2023
In adolescents and adults with AD, ruxolitinib cream showed a rapid reduction in itch within about 12 hours of the first application. Atopic dermatitis (AD) significantly impacts patient quality of life (QoL) and imposes a…
MDNewsline DailyJanuary 30, 2023
Atopic dermatitis affects the mental health of adolescents, which in turn affects their psychological well-being. Atopic dermatitis (AD) is an inflammatory, chronic, relapsing skin condition characterized by eczematous lesions and itching, negatively impacting quality of…
MDNewsline DailyJanuary 25, 2023
Abrocitinib, an oral Janus kinase (JAK) 1 inhibitor, provides an efficacious alternative for adults nonresponsive to other systemic therapies. Atopic Dermatitis (AD) affects 1% to 3% of adults and 15% to 20% of children globally.…
MDNewsline DailyJanuary 25, 2023
In everyday practice, upadacitinib can be a successful treatment for patients with atopic dermatitis and concurrent hand eczema. These findings are reported in a multicenter observational cohort study published in Contact Dermatitis that aims to…
MDNewsline DailyJanuary 25, 2023
Food allergy is common in moderate-to-severe and early-onset atopic dermatitis. Accurate detection of food allergies is essential for increasing treatment efficacy and preventing unnecessary diets. Atopic dermatitis (AD) is a chronic, recurring, inflammatory skin condition…
MDNewsline DailyJanuary 23, 2023
Patients with immunodeficiencies and antibody deficiencies typically have atopic symptoms, which should be addressed to avoid worsening of the condition. Primary immunodeficiency diseases (PIDs) are a heterogeneous set of more than 300 inherited immunity abnormalities…
MDNewsline DailyJanuary 13, 2023
On November 17th, 2022, in our recent webcast titled "Exploring Vitiligo Treatment Options", Dr. Brittany Oliver, a Board-Certified Dermatologist, answers questions from Dr. Pete Thomas on treatment options for Vitiligo. Dr. Brittany Oliver is an…
Daysha RobinsonNovember 21, 2022
This 52-week phase 3 atopic dermatitis (AD) study indicates that upadacitinib with topical corticosteroids has the potential to be a successful and well-tolerated long-term treatment option for people with moderate-to-severe atopic dermatitis. Atopic dermatitis (AD)…
Daysha RobinsonNovember 16, 2022